Drug Trial Radar · NCT07136779
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
Last checked: Nov 19, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
310
Planned (sponsor's estimate)
Start
Sep 23, 2025
Primary completion
Jul 1, 2027
Study completion Jul 1, 2028
Sponsor
- Lead sponsor
- VelaVigo Bio IncIndustry
- Sponsor type
- Industry
- First posted
- Aug 22, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, open-label, multiple-dose, FIH Phase 1/2a trial. The Phase 1 portion adopts an accelerated titration for the first dose level, followed by BOIN design to identify the MTD and/or RP2D with potential backfill cohorts. The Phase 2a portion consists of dose optimization followed by cohort expansion to confirm safety and tolerability and to further evaluate the efficacy of the selected RP2D in selected solid tumor malignancies for VBC101.
Conditions
- Participants With Advanced Solid Tumor Malignancies
Interventions
VBC101Drug
VBC101
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of dose-limiting toxicities (DLT) as defined in the protocolTime frame: (DLT)From time of first dose of VBC101 to end of DLT period (approximately 21 days)
- Incidence of Serious Adverse EventsTime frame: From time of Informed Consent to 30 days post last dose of VBC101
- Incidence of Adverse Events(AEs)Time frame: From time of Informed Consent to 30 days post last dose of VBC101
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Start Midwest
Grand Rapids, Michigan · Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas · Recruiting
NEXT Oncology
San Antonio, Texas · Recruiting
START Mountain Region, LLC.
West Valley City, Utah · Recruiting
NEXT Virginia
Fairfax, Virginia · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.